Oleanolic acid ameliorates cognitive dysfunction caused by cholinergic blockade via TrkB-dependent BDNF signaling

Area of Science:

• Neuroscience
• Pharmacology
• Natural Products Chemistry

Background:

• Cognitive deficits, often induced by cholinergic blockade, represent a significant challenge.
• Oleanolic acid, a natural triterpenoid found in plants, has shown potential in various biological activities.

Purpose of the Study:

• To investigate the effects of oleanolic acid on memory impairment induced by scopolamine in a mouse model.
• To elucidate the underlying molecular mechanisms, including the role of the TrkB-BDNF pathway.

Main Methods:

• A cholinergic blockade-induced cognitive deficit mouse model was utilized.
• Behavioral tasks including passive avoidance, Y-maze, and novel object recognition were performed.
• Hippocampal protein expression and phosphorylation (ERK1/2, CREB) were analyzed.
• Electrophysiology studies assessed long-term potentiation, with and without TrkB inhibition (ANA-12).

Main Results:

• Oleanolic acid administration reversed scopolamine-induced memory deficits across multiple behavioral tests.
• It enhanced hippocampal phosphorylation of ERK1/2 and CREB, and increased BDNF expression.
• The memory-ameliorating effects of oleanolic acid were blocked by ANA-12, a TrkB inhibitor.
• Oleanolic acid induced dose-dependent long-term potentiation, which was attenuated by ANA-12.

Conclusions:

• Oleanolic acid effectively ameliorates scopolamine-induced memory impairment in mice.
• The mechanism involves the modulation of the BDNF-ERK1/2-CREB pathway via activation of TrkB.
• Oleanolic acid shows promise as a potential therapeutic agent for cognitive deficits.